Study: CBD Found to Disrupt Key Infection Mechanisms of Listeria
- CBD significantly reduces the ability of Listeria monocytogenes to infect and damage host cells by impairing key virulence mechanisms without killing the bacteria outright.
- At sub-inhibitory concentrations, CBD decreases bacterial motility and toxin production, including hemolysin and lecithinase, which are vital for disease progression.
- CBD hampers the pathogen’s adherence to and invasion of human intestinal and brain endothelial cells by downregulating genes linked to virulence factors.
- In a live infection model, CBD improved survival rates dose-dependently but showed potential cytotoxicity at higher concentrations, suggesting a need for careful dosing in therapeutic applications.
A new study published in the International Journal of Molecular Sciences found that cannabidiol (CBD) may significantly reduce the ability of Listeria monocytogenes to infect and damage host cells, pointing to potential applications in both food safety and treatment strategies.
The study, conducted by researchers from the University of Connecticut, University of Florida and the United States Department of Agriculture, examined how CBD impacts multiple virulence mechanisms of the foodborne pathogen. Rather than killing the bacteria outright, researchers focused on how CBD affects its ability to cause disease.
Using two strains of Listeria monocytogenes, the researchers identified both inhibitory and sub-inhibitory concentrations of CBD, allowing them to test its effects without completely halting bacterial growth. At higher sub-inhibitory levels, CBD was found to significantly reduce bacterial motility, as well as the production of key toxins including hemolysin and lecithinase.
The compound also impaired the pathogen’s ability to adhere to and invade human intestinal and brain endothelial cells, which are critical steps in the progression of infection. Further analysis revealed that CBD downregulated several genes responsible for virulence, including those tied to toxin production, movement, and host cell invasion.
In a live infection model using Galleria mellonella larvae, CBD treatment improved survival rates in a dose-dependent manner. However, the study also found that higher concentrations of CBD may introduce toxicity, with cytotoxic effects observed above certain thresholds.
Researchers concluded that CBD can effectively suppress multiple disease-causing mechanisms in Listeria monocytogenes without necessarily eliminating the bacteria itself. This anti-virulence approach may offer a promising alternative to traditional antimicrobial strategies, particularly in reducing the risk of severe infection while limiting the pressure that drives antibiotic resistance.